©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13863-13878
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13863
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13863
Table 3 Acquired and hereditary thrombotic risk factors in inflammatory bowel disease patients
| Factors | Mechanism |
| Acquired | |
| Inflammation | Hypercoagulation, vascular endothelial injury |
| Immobilization | Stasis |
| Indwelling IV catheters | Vascular injury |
| Dehydration | Stasis |
| Steroid use | Hypercoagulation |
| Oral contraceptives | Hypercoagulation |
| Surgery | Stasis, hypercoagulation, vascular injury |
| Pregnancy | Stasis, hypercoagulation |
| Cancer | Hypercoagulation |
| Infections | Hypercoagulation |
| Age | Hypercoagulation |
| Smoking | Hypercoagulation |
| Hereditary | |
| Proteins C and S deficiencies | Hypercoagulation |
| Antithrombin deficiency | Hypercoagulation |
| Factor V Leiden | Hypercoagulation |
| Hyperhomocysteinemia-MTHFR gene mutation | Hypercoagulation |
| Prothrombin gene mutation G20210A | Hypercoagulation |
| Dysfibrinogenemia | Hypercoagulation |
- Citation: Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism. World J Gastroenterol 2014; 20(38): 13863-13878
- URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13863.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13863